Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vorst

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Leukemia & Lymphoma|April 8, 1999
B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent courseL Shvidel, M Shtalrid, L Bassous, et al.
American Journal of Hematology|July 1, 1990
Further characterization of prolymphocytic leukemia cells as a tumor of activated B cellsA Berrebi, L Bassous-Guedj, E Vorst, et al.
American Journal of Hematology|August 1, 1988
Gray platelet syndrome in the elderlyA Berrebi, A Klepfish, D Varon, et al.
Leukemia|October 12, 2007
A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndromeL Shvidel, E Sigler, E Vorst, et al.
Leukemia|December 1, 1994
Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemiaA Berrebi, M Shtalrid, A Klepfish, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Leukemia & Lymphoma|April 8, 1999
B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent courseL Shvidel, M Shtalrid, L Bassous, et al.
American Journal of Hematology|July 1, 1990
Further characterization of prolymphocytic leukemia cells as a tumor of activated B cellsA Berrebi, L Bassous-Guedj, E Vorst, et al.
American Journal of Hematology|August 1, 1988
Gray platelet syndrome in the elderlyA Berrebi, A Klepfish, D Varon, et al.
Leukemia|October 12, 2007
A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndromeL Shvidel, E Sigler, E Vorst, et al.
Leukemia|December 1, 1994
Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemiaA Berrebi, M Shtalrid, A Klepfish, et al.
Pageof 2